A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054): Difference between revisions
From MaRDI portal
Latest revision as of 22:42, 4 July 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity |
scientific article |
Statements
A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (English)
0 references
5 March 2012
0 references
Bayesian design
0 references
treatment selection
0 references
0 references
0 references